Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, Denise A. Yardley et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison Stopeck, Ada Braun, Karim Fizazi et al.|Supportive Care in Cancer|2015Cited by 190
Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Jean‐Jacques Body et al.|Cancer|2012Cited by 155
P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.A. Stopeck, Ada Braun, Allan Lipton et al.|Cancer Research|2011Cited by 15